STAAR Surgical markets phakic IOL in Canada

July 6, 2005

The Canadian Therapeutic Products Directorate said it granted approval for STAAR Surgical Co. to market its STAAR Visian Toric lens (TICL) in Canada.

The Canadian Therapeutic Products Directorate said it granted approval for STAAR Surgical Co. to market its STAAR Visian Toric lens (TICL) in Canada.

The posterior chamber phakic IOL is the first to be approved to correct both myopia and astigmatism in a single procedure, the company said in a prepared statement.

Used as part of the customized refractive procedure, the IOL offers a solution that corrects these vision deficiencies without the removal or destruction of corneal tissue, according to the company.